Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma is a research paper published in Radiology (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P50CA101942
National Institutes of Health
Grant: P50CA196516
Pfizer
Grant: WS277615
GlaxoSmithKline
Grant: CPZP034AUS53T
National Institutes of Health
Grant: 5P50CA196516-05
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
National Institutes of Health
Grant: 2P50CA101942-11A1
DF/HCC Kidney Cancer SPORE
National Institutes of Health
Grant: 1U01CA207091-01A1
Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy Response
National Institutes of Health
Grant: 2R01CA154475-06A1
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA
NCI NIH HHS
Grant: R01 CA154475
NCI NIH HHS
Grant: U01 CA207091
FWCI
1.43
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals